The Antiobesity Effects of Buginawa in 3T3-L1 Preadipocytes and in a Mouse Model of High-Fat Diet-Induced Obesity

Figure 2

Bugi inhibits body weight and abdominal fat content in mice with HFD-induced obesity. (a) Body weight (BW) and (c) food intake were recorded every week. (b) Final body weight gain and (d) abdominal fat content were checked at the end of 11 weeks of experiments. (d) The values represent the mean ± S.D. ^#p < 0.05 and ^###p < 0.001 vs. the CON group; p < 0.05 and p < 0.001 vs. HFD group.

(a)

(b)

(c)

(d)